• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超声乳化白内障吸除术后在假性剥脱综合征和原发性开角型青光眼。

Uneventful Phacoemulsification after Trabeculectomy in Pseudoexfoliation Glaucoma versus Primary Open-Angle Glaucoma.

机构信息

Ophthalmology Department, Health Sciences University Turkey, Haydarpaşa Numune Research and Training Hospital, Istanbul, Turkey.

出版信息

Ophthalmic Res. 2023;66(1):672-680. doi: 10.1159/000529642. Epub 2023 Feb 23.

DOI:10.1159/000529642
PMID:36822166
Abstract

INTRODUCTION

Conflicting results have been reported on phacoemulsification in the filtered eyes with open-angle glaucoma. In this study, we aim to compare the effect of phacoemulsification after trabeculectomy between pseudoexfoliation glaucoma (XFG) and primary open-angle glaucoma (POAG).

METHODS

Consecutive patients with XFG and POAG who underwent uneventful phacoemulsification after trabeculectomy with 5-fluorouracil (TRAB-PHACO group) were reviewed retrospectively and matched to patients who underwent trabeculectomy only (TRAB group). Comparisons were performed for IOP, medication numbers, and success rates. Surgical failure was defined as IOP >21 mm Hg or IOP ≤21 mm Hg with additional medication or glaucoma surgery. Survival analysis was investigated by Kaplan-Meier test and the factors influencing final success by multivariate logistic regression analysis.

RESULTS

The records of 204 patients were reviewed. In XFG, when compared with the baseline, increase in IOP became statistically significant at the at 24-month visit in the TRAB-PHACO group (p = 0.002), at the 6-month visit (p = 0.001) in the TRAB group and remained so throughout the follow-up. In the TRAB-PHACO group, increase of glaucoma medications was statistically significant only at the last visit (p = 0.001) in XFG, at the 6-month visit (p = 0.02) in POAG and remained so throughout the follow-up. Two glaucoma types did not differ statistically from one another in terms of survival analysis. In the TRAB group, the additional glaucoma surgery was more common in XFG compared to POAG (p = 0.02). The trabeculectomy failure after phacoemulsification was related with an IOP spike >25 mm Hg at postoperative first 24h (p = 0.04).

CONCLUSIONS

In the filtered eyes with XFG, uneventful phacoemulsification may delay time-related worsening in IOP control and may decrease the additional glaucoma surgery need.

摘要

简介

在开角型青光眼滤过过的眼中,超声乳化术的结果存在争议。本研究旨在比较原发性开角型青光眼(POAG)和假性剥脱综合征(XFG)患者小梁切除术后行超声乳化术的效果。

方法

回顾性分析了 204 例连续接受无并发症超声乳化术联合 5-氟尿嘧啶(TRAB-PHACO 组)治疗的 XFG 和 POAG 患者的临床资料,并与仅接受小梁切除术(TRAB 组)的患者进行了匹配。比较两组患者的眼压(IOP)、药物使用数量和成功率。手术失败定义为 IOP>21mmHg 或 IOP≤21mmHg 需加用药物或行青光眼手术。采用 Kaplan-Meier 检验进行生存分析,采用多因素逻辑回归分析影响最终成功率的因素。

结果

在 XFG 中,与基线相比,TRAB-PHACO 组患者在术后 24 个月(p=0.002)、TRAB 组患者在术后 6 个月(p=0.001)时 IOP 升高有统计学意义,且在整个随访过程中一直如此。在 TRAB-PHACO 组中,XFG 患者仅在最后一次随访时(p=0.001)、POAG 患者在术后 6 个月时(p=0.02)需要增加青光眼药物治疗,且在整个随访过程中一直如此。两种青光眼类型在生存分析方面无统计学差异。在 TRAB 组中,XFG 患者比 POAG 患者更需要行额外的青光眼手术(p=0.02)。超声乳化术后小梁切除术失败与术后 24 小时内 IOP 升高>25mmHg 有关(p=0.04)。

结论

在 XFG 滤过过的眼中,超声乳化术可能会延迟眼压控制的时间相关性恶化,并可能减少额外的青光眼手术需求。

相似文献

1
Uneventful Phacoemulsification after Trabeculectomy in Pseudoexfoliation Glaucoma versus Primary Open-Angle Glaucoma.超声乳化白内障吸除术后在假性剥脱综合征和原发性开角型青光眼。
Ophthalmic Res. 2023;66(1):672-680. doi: 10.1159/000529642. Epub 2023 Feb 23.
2
Two-Year Outcomes of Trabeculectomy and Phacotrabeculectomy in Primary Open Angle Versus Primary Angle Closure Glaucoma.原发性开角型青光眼与原发性闭角型青光眼小梁切除术和晶状体切除小梁切除术的两年疗效
J Glaucoma. 2023 May 1;32(5):374-381. doi: 10.1097/IJG.0000000000002172. Epub 2023 Jan 3.
3
Comparison of long-term results of trabeculectomy and phacotrabeculectomy in patients with pseudoexfoliation glaucoma and primary open-angle glaucoma: a single-center study.超声乳化白内障吸除联合小梁切除术与小梁切除术治疗原发性开角型青光眼合并假性剥脱综合征的长期疗效比较:单中心研究。
Int Ophthalmol. 2022 Jun;42(6):1737-1747. doi: 10.1007/s10792-021-02169-2. Epub 2022 Jan 27.
4
Long-term Outcomes of Mitomycin-C Trabeculectomy in Exfoliative Glaucoma Versus Primary Open-Angle Glaucoma.丝裂霉素C小梁切除术治疗剥脱性青光眼与原发性开角型青光眼的长期疗效
J Glaucoma. 2017 Apr;26(4):303-310. doi: 10.1097/IJG.0000000000000365.
5
Combined cataract and trabeculectomy surgery in eyes with pseudoexfoliation glaucoma.合并白内障和小梁切除术治疗假性剥脱性青光眼的眼睛。
J Cataract Refract Surg. 2011 Nov;37(11):1961-70. doi: 10.1016/j.jcrs.2011.05.036. Epub 2011 Sep 9.
6
Intraocular pressure control after clear corneal phacoemulsification in eyes with previous trabeculectomy: a controlled study.既往行小梁切除术的眼睛在透明角膜超声乳化术后的眼压控制:一项对照研究。
Acta Ophthalmol Scand. 2005 Oct;83(5):554-60. doi: 10.1111/j.1600-0420.2005.00497.x.
7
3-Year Outcomes of XEN Implant Compared With Trabeculectomy, With or Without Phacoemulsification for Open Angle Glaucoma.XEN植入术与小梁切除术治疗开角型青光眼(无论是否联合白内障超声乳化术)的3年疗效比较
J Glaucoma. 2022 Oct 1;31(10):826-833. doi: 10.1097/IJG.0000000000002090. Epub 2022 Aug 1.
8
Deep sclerectomy versus punch trabeculectomy with or without phacoemulsification: a randomized clinical trial.深层巩膜切除术与有或无超声乳化白内障吸除术的穿刺小梁切除术:一项随机临床试验
J Glaucoma. 2004 Dec;13(6):500-6. doi: 10.1097/01.ijg.0000137869.18156.81.
9
Comparison of the 1-year postoperative results of phacoemulsification-trabeculectomy and phacoemulsification-ExPRESS miniature shunt combined surgeries.超声乳化白内障吸除术联合小梁切除术与超声乳化白内障吸除术联合 ExPRESS 微型分流器手术的 1 年术后结果比较。
Int Ophthalmol. 2020 Jun;40(6):1517-1529. doi: 10.1007/s10792-020-01321-8. Epub 2020 Feb 25.
10
Temporal corneal phacoemulsification in filtered glaucoma patients.滤过性青光眼患者的颞侧角膜超声乳化术
Trans Am Ophthalmol Soc. 1997;95:153-67; discussion 167-70.

引用本文的文献

1
Comparison of Phacoemulsification Alone and With Trabecular Microbypass Stent in Primary Open-Angle Glaucoma and Normal-Tension Glaucoma: An 18-Month Outcome Study.单纯超声乳化术与小梁微旁路支架植入术治疗原发性开角型青光眼和正常眼压性青光眼的比较:一项18个月的疗效研究。
J Ophthalmol. 2024 Nov 7;2024:4034215. doi: 10.1155/2024/4034215. eCollection 2024.